Former UFC heavyweight champion has been notified by the US Anti-Doping Agency of a failed out-of-competition drug test on 28 June
Brock Lesnar has been flagged for a potential anti-doping misdemeanor in the wake of his unanimous-decision win over Mark Hunt at UFC 200.
The UFC problem a declaration on Friday afternoon saying Lesnar and the publicity had been notified by the US Anti-Doping Agency of a failed out-of-competition medication research on 28 June. Usada did not reveal the name of the substance Lesnar tested positive for in keeping with managerial policy.
A embellished amateur wrestler, Lesnar signed with the UFC in 2007 and defeated Randy Couture for the advertisements heavyweight championship the subsequent year. He realized two successful entitlement defenses before losing to Cain Velasquez by first-round TKO, then announced his retirement from mixed martial art after a strike loss to Alistair Overeem in 2011.
Saturdays fight with Hunt was Lesnars firstly in five years old. The 38 -year-old South Dakota native gave a record $2.5 m purse for the three-round details acquire, with all three judges handing down scores of 29 -2 8.
The UFC said Usada, the independent administrator of the organisation anti-doping policy, received the testing results from the 28 June sample collect on Thursday evening after it was experimented at the Wada-accredited UCLA Olympic Analytical Laboratory.
The original headline bout of Saturdays card a light-colored heavyweight entitlement battle between Jon Jones and Daniel Cormier was scrapped when Jones is positive for a banned substance. Cormier instead contended Anderson Silva on the undercard, while the womens bantamweight championship contend between Amanda Nunes and Miesha Tate was elevated to the main event.
The UFC 200 main event had to be scrapped three days before the affair because Jon Jones tested positive for censored essences in an out-of-competition research. Daniel Cormier crusaded Anderson Silva instead. Jones is also awaiting the USADA adjudication process.
Read more: www.theguardian.com